Site intended for UK
audience
Site intended for UK
audience
Trigelan® contains the three active substances levodopa, carbidopa and entacapone in one film-coated tablet.
Trigelan® is a medicine used to treat Parkinson’s disease.
Parkinson’s is caused by a deficiency of the neurotransmitter dopamine in the brain. Levodopa increases the amount of dopamine and thus reduces the symptoms of Parkinson’s disease. Carbidopa and entacapone improve the antiparkinsonian effects of levodopa.
| Strength | Pack size |
| 50 mg/12,5 mg/200 mg | 30, 100 |
| 100 mg/25 mg/200 mg | 30, 100 |
| 150 mg/37,5 mg/200 mg | 30, 100 |
| 200 mg/50 mg/200 mg | 30, 100 |
We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.
Login
